# [FOXO1]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |1   |
|DLBCL |1   |
|FL    |1   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture|23.33        |
|BL    |Thomas cohort        |28.00        |
|BL    |Panea cohort         |21.80        |
|DLBCL |GAMBL genomes        |10.60        |
|DLBCL |Schmitz cohort       | 7.20        |
|DLBCL |Reddy cohort         | 2.40        |
|DLBCL |Chapuy cohort        | 2.10        |
|FL    |GAMBL genomes        |12.93        |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |No  |Yes                  |14.841          |  5.170         |
|DLBCL |No  |No                   | 6.936          |  0.000         |
|FL    |No  |Yes                  |18.992          |103.028         |


> [!NOTE]
> First described in BL in 2012 by [Schmitz R](https://pubmed.ncbi.nlm.nih.gov/22885699). First described in DLBCL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119). First described in FL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119)